Request for Covid-19 Impact Assessment of this Report
The United States Antibiotic Resistance market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Antibiotic Resistance market, reaching US$ million by the year 2028. As for the Europe Antibiotic Resistance landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Antibiotic Resistance players cover Allergan, AmpliPhi Biosciences, BioVersys GmbH, and Macrolide Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibiotic Resistance market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
By Disease
By Pathogen
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Oxazolidinones
Lipoglycopeptides
Tetracyclines
Cephalosporins
Combination therapies
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Allergan
AmpliPhi Biosciences
BioVersys GmbH
Macrolide Pharmaceuticals
Melinta Therapeutics
Merck
Nabriva Therapeutics
Nemesis Bioscience
Phage Technologies S.A
Tetraphase Pharmaceuticals
The Medicines Company
TPfizer
Westway Health
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antibiotic Resistance Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Antibiotic Resistance by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Antibiotic Resistance by Country/Region, 2017, 2022 & 2028
2.2 Antibiotic Resistance Segment by Type
2.2.1 Type I
2.2.2 Type II
2.3 Antibiotic Resistance Sales by Type
2.3.1 Global Antibiotic Resistance Sales Market Share by Type (2017-2022)
2.3.2 Global Antibiotic Resistance Revenue and Market Share by Type (2017-2022)
2.3.3 Global Antibiotic Resistance Sale Price by Type (2017-2022)
2.4 Antibiotic Resistance Segment by Application
2.4.1 Oxazolidinones
2.4.2 Lipoglycopeptides
2.4.3 Tetracyclines
2.4.4 Cephalosporins
2.4.5 Combination therapies
2.4.6 Other
2.5 Antibiotic Resistance Sales by Application
2.5.1 Global Antibiotic Resistance Sale Market Share by Application (2017-2022)
2.5.2 Global Antibiotic Resistance Revenue and Market Share by Application (2017-2022)
2.5.3 Global Antibiotic Resistance Sale Price by Application (2017-2022)
3 Global Antibiotic Resistance by Company
3.1 Global Antibiotic Resistance Breakdown Data by Company
3.1.1 Global Antibiotic Resistance Annual Sales by Company (2020-2022)
3.1.2 Global Antibiotic Resistance Sales Market Share by Company (2020-2022)
3.2 Global Antibiotic Resistance Annual Revenue by Company (2020-2022)
3.2.1 Global Antibiotic Resistance Revenue by Company (2020-2022)
3.2.2 Global Antibiotic Resistance Revenue Market Share by Company (2020-2022)
3.3 Global Antibiotic Resistance Sale Price by Company
3.4 Key Manufacturers Antibiotic Resistance Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antibiotic Resistance Product Location Distribution
3.4.2 Players Antibiotic Resistance Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Antibiotic Resistance by Geographic Region
4.1 World Historic Antibiotic Resistance Market Size by Geographic Region (2017-2022)
4.1.1 Global Antibiotic Resistance Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Antibiotic Resistance Annual Revenue by Geographic Region
4.2 World Historic Antibiotic Resistance Market Size by Country/Region (2017-2022)
4.2.1 Global Antibiotic Resistance Annual Sales by Country/Region (2017-2022)
4.2.2 Global Antibiotic Resistance Annual Revenue by Country/Region
4.3 Americas Antibiotic Resistance Sales Growth
4.4 APAC Antibiotic Resistance Sales Growth
4.5 Europe Antibiotic Resistance Sales Growth
4.6 Middle East & Africa Antibiotic Resistance Sales Growth
5 Americas
5.1 Americas Antibiotic Resistance Sales by Country
5.1.1 Americas Antibiotic Resistance Sales by Country (2017-2022)
5.1.2 Americas Antibiotic Resistance Revenue by Country (2017-2022)
5.2 Americas Antibiotic Resistance Sales by Type
5.3 Americas Antibiotic Resistance Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibiotic Resistance Sales by Region
6.1.1 APAC Antibiotic Resistance Sales by Region (2017-2022)
6.1.2 APAC Antibiotic Resistance Revenue by Region (2017-2022)
6.2 APAC Antibiotic Resistance Sales by Type
6.3 APAC Antibiotic Resistance Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Antibiotic Resistance by Country
7.1.1 Europe Antibiotic Resistance Sales by Country (2017-2022)
7.1.2 Europe Antibiotic Resistance Revenue by Country (2017-2022)
7.2 Europe Antibiotic Resistance Sales by Type
7.3 Europe Antibiotic Resistance Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antibiotic Resistance by Country
8.1.1 Middle East & Africa Antibiotic Resistance Sales by Country (2017-2022)
8.1.2 Middle East & Africa Antibiotic Resistance Revenue by Country (2017-2022)
8.2 Middle East & Africa Antibiotic Resistance Sales by Type
8.3 Middle East & Africa Antibiotic Resistance Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antibiotic Resistance
10.3 Manufacturing Process Analysis of Antibiotic Resistance
10.4 Industry Chain Structure of Antibiotic Resistance
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antibiotic Resistance Distributors
11.3 Antibiotic Resistance Customer
12 World Forecast Review for Antibiotic Resistance by Geographic Region
12.1 Global Antibiotic Resistance Market Size Forecast by Region
12.1.1 Global Antibiotic Resistance Forecast by Region (2023-2028)
12.1.2 Global Antibiotic Resistance Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antibiotic Resistance Forecast by Type
12.7 Global Antibiotic Resistance Forecast by Application
13 Key Players Analysis
13.1 Allergan
13.1.1 Allergan Company Information
13.1.2 Allergan Antibiotic Resistance Product Offered
13.1.3 Allergan Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Allergan Main Business Overview
13.1.5 Allergan Latest Developments
13.2 AmpliPhi Biosciences
13.2.1 AmpliPhi Biosciences Company Information
13.2.2 AmpliPhi Biosciences Antibiotic Resistance Product Offered
13.2.3 AmpliPhi Biosciences Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AmpliPhi Biosciences Main Business Overview
13.2.5 AmpliPhi Biosciences Latest Developments
13.3 BioVersys GmbH
13.3.1 BioVersys GmbH Company Information
13.3.2 BioVersys GmbH Antibiotic Resistance Product Offered
13.3.3 BioVersys GmbH Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 BioVersys GmbH Main Business Overview
13.3.5 BioVersys GmbH Latest Developments
13.4 Macrolide Pharmaceuticals
13.4.1 Macrolide Pharmaceuticals Company Information
13.4.2 Macrolide Pharmaceuticals Antibiotic Resistance Product Offered
13.4.3 Macrolide Pharmaceuticals Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Macrolide Pharmaceuticals Main Business Overview
13.4.5 Macrolide Pharmaceuticals Latest Developments
13.5 Melinta Therapeutics
13.5.1 Melinta Therapeutics Company Information
13.5.2 Melinta Therapeutics Antibiotic Resistance Product Offered
13.5.3 Melinta Therapeutics Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Melinta Therapeutics Main Business Overview
13.5.5 Melinta Therapeutics Latest Developments
13.6 Merck
13.6.1 Merck Company Information
13.6.2 Merck Antibiotic Resistance Product Offered
13.6.3 Merck Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Merck Main Business Overview
13.6.5 Merck Latest Developments
13.7 Nabriva Therapeutics
13.7.1 Nabriva Therapeutics Company Information
13.7.2 Nabriva Therapeutics Antibiotic Resistance Product Offered
13.7.3 Nabriva Therapeutics Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Nabriva Therapeutics Main Business Overview
13.7.5 Nabriva Therapeutics Latest Developments
13.8 Nemesis Bioscience
13.8.1 Nemesis Bioscience Company Information
13.8.2 Nemesis Bioscience Antibiotic Resistance Product Offered
13.8.3 Nemesis Bioscience Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Nemesis Bioscience Main Business Overview
13.8.5 Nemesis Bioscience Latest Developments
13.9 Phage Technologies S.A
13.9.1 Phage Technologies S.A Company Information
13.9.2 Phage Technologies S.A Antibiotic Resistance Product Offered
13.9.3 Phage Technologies S.A Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Phage Technologies S.A Main Business Overview
13.9.5 Phage Technologies S.A Latest Developments
13.10 Tetraphase Pharmaceuticals
13.10.1 Tetraphase Pharmaceuticals Company Information
13.10.2 Tetraphase Pharmaceuticals Antibiotic Resistance Product Offered
13.10.3 Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Tetraphase Pharmaceuticals Main Business Overview
13.10.5 Tetraphase Pharmaceuticals Latest Developments
13.11 The Medicines Company
13.11.1 The Medicines Company Company Information
13.11.2 The Medicines Company Antibiotic Resistance Product Offered
13.11.3 The Medicines Company Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 The Medicines Company Main Business Overview
13.11.5 The Medicines Company Latest Developments
13.12 TPfizer
13.12.1 TPfizer Company Information
13.12.2 TPfizer Antibiotic Resistance Product Offered
13.12.3 TPfizer Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 TPfizer Main Business Overview
13.12.5 TPfizer Latest Developments
13.13 Westway Health
13.13.1 Westway Health Company Information
13.13.2 Westway Health Antibiotic Resistance Product Offered
13.13.3 Westway Health Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Westway Health Main Business Overview
13.13.5 Westway Health Latest Developments
14 Research Findings and Conclusion
Table 1. Antibiotic Resistance Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Antibiotic Resistance Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Type I
Table 4. Major Players of Type I
Table 5. Global Antibiotic Resistance Sales by Type (2017-2022) & (K Pcs)
Table 6. Global Antibiotic Resistance Sales Market Share by Type (2017-2022)
Table 7. Global Antibiotic Resistance Revenue by Type (2017-2022) & ($ million)
Table 8. Global Antibiotic Resistance Revenue Market Share by Type (2017-2022)
Table 9. Global Antibiotic Resistance Sale Price by Type (2017-2022) & (USD/Pcs)
Table 10. Global Antibiotic Resistance Sales by Application (2017-2022) & (K Pcs)
Table 11. Global Antibiotic Resistance Sales Market Share by Application (2017-2022)
Table 12. Global Antibiotic Resistance Revenue by Application (2017-2022)
Table 13. Global Antibiotic Resistance Revenue Market Share by Application (2017-2022)
Table 14. Global Antibiotic Resistance Sale Price by Application (2017-2022) & (USD/Pcs)
Table 15. Global Antibiotic Resistance Sales by Company (2020-2022) & (K Pcs)
Table 16. Global Antibiotic Resistance Sales Market Share by Company (2020-2022)
Table 17. Global Antibiotic Resistance Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Antibiotic Resistance Revenue Market Share by Company (2020-2022)
Table 19. Global Antibiotic Resistance Sale Price by Company (2020-2022) & (USD/Pcs)
Table 20. Key Manufacturers Antibiotic Resistance Producing Area Distribution and Sales Area
Table 21. Players Antibiotic Resistance Products Offered
Table 22. Antibiotic Resistance Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Antibiotic Resistance Sales by Geographic Region (2017-2022) & (K Pcs)
Table 26. Global Antibiotic Resistance Sales Market Share Geographic Region (2017-2022)
Table 27. Global Antibiotic Resistance Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Antibiotic Resistance Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Antibiotic Resistance Sales by Country/Region (2017-2022) & (K Pcs)
Table 30. Global Antibiotic Resistance Sales Market Share by Country/Region (2017-2022)
Table 31. Global Antibiotic Resistance Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Antibiotic Resistance Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Antibiotic Resistance Sales by Country (2017-2022) & (K Pcs)
Table 34. Americas Antibiotic Resistance Sales Market Share by Country (2017-2022)
Table 35. Americas Antibiotic Resistance Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Antibiotic Resistance Revenue Market Share by Country (2017-2022)
Table 37. Americas Antibiotic Resistance Sales by Type (2017-2022) & (K Pcs)
Table 38. Americas Antibiotic Resistance Sales Market Share by Type (2017-2022)
Table 39. Americas Antibiotic Resistance Sales by Application (2017-2022) & (K Pcs)
Table 40. Americas Antibiotic Resistance Sales Market Share by Application (2017-2022)
Table 41. APAC Antibiotic Resistance Sales by Region (2017-2022) & (K Pcs)
Table 42. APAC Antibiotic Resistance Sales Market Share by Region (2017-2022)
Table 43. APAC Antibiotic Resistance Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Antibiotic Resistance Revenue Market Share by Region (2017-2022)
Table 45. APAC Antibiotic Resistance Sales by Type (2017-2022) & (K Pcs)
Table 46. APAC Antibiotic Resistance Sales Market Share by Type (2017-2022)
Table 47. APAC Antibiotic Resistance Sales by Application (2017-2022) & (K Pcs)
Table 48. APAC Antibiotic Resistance Sales Market Share by Application (2017-2022)
Table 49. Europe Antibiotic Resistance Sales by Country (2017-2022) & (K Pcs)
Table 50. Europe Antibiotic Resistance Sales Market Share by Country (2017-2022)
Table 51. Europe Antibiotic Resistance Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Antibiotic Resistance Revenue Market Share by Country (2017-2022)
Table 53. Europe Antibiotic Resistance Sales by Type (2017-2022) & (K Pcs)
Table 54. Europe Antibiotic Resistance Sales Market Share by Type (2017-2022)
Table 55. Europe Antibiotic Resistance Sales by Application (2017-2022) & (K Pcs)
Table 56. Europe Antibiotic Resistance Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Antibiotic Resistance Sales by Country (2017-2022) & (K Pcs)
Table 58. Middle East & Africa Antibiotic Resistance Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Antibiotic Resistance Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Antibiotic Resistance Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Antibiotic Resistance Sales by Type (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Antibiotic Resistance Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Antibiotic Resistance Sales by Application (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Antibiotic Resistance Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Antibiotic Resistance
Table 66. Key Market Challenges & Risks of Antibiotic Resistance
Table 67. Key Industry Trends of Antibiotic Resistance
Table 68. Antibiotic Resistance Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Antibiotic Resistance Distributors List
Table 71. Antibiotic Resistance Customer List
Table 72. Global Antibiotic Resistance Sales Forecast by Region (2023-2028) & (K Pcs)
Table 73. Global Antibiotic Resistance Sales Market Forecast by Region
Table 74. Global Antibiotic Resistance Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Antibiotic Resistance Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Antibiotic Resistance Sales Forecast by Country (2023-2028) & (K Pcs)
Table 77. Americas Antibiotic Resistance Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Antibiotic Resistance Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. APAC Antibiotic Resistance Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Antibiotic Resistance Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Europe Antibiotic Resistance Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Antibiotic Resistance Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Middle East & Africa Antibiotic Resistance Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Antibiotic Resistance Sales Forecast by Type (2023-2028) & (K Pcs)
Table 85. Global Antibiotic Resistance Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Antibiotic Resistance Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Antibiotic Resistance Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Antibiotic Resistance Sales Forecast by Application (2023-2028) & (K Pcs)
Table 89. Global Antibiotic Resistance Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Antibiotic Resistance Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Antibiotic Resistance Revenue Market Share Forecast by Application (2023-2028)
Table 92. Allergan Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors
Table 93. Allergan Antibiotic Resistance Product Offered
Table 94. Allergan Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 95. Allergan Main Business
Table 96. Allergan Latest Developments
Table 97. AmpliPhi Biosciences Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors
Table 98. AmpliPhi Biosciences Antibiotic Resistance Product Offered
Table 99. AmpliPhi Biosciences Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 100. AmpliPhi Biosciences Main Business
Table 101. AmpliPhi Biosciences Latest Developments
Table 102. BioVersys GmbH Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors
Table 103. BioVersys GmbH Antibiotic Resistance Product Offered
Table 104. BioVersys GmbH Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 105. BioVersys GmbH Main Business
Table 106. BioVersys GmbH Latest Developments
Table 107. Macrolide Pharmaceuticals Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors
Table 108. Macrolide Pharmaceuticals Antibiotic Resistance Product Offered
Table 109. Macrolide Pharmaceuticals Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 110. Macrolide Pharmaceuticals Main Business
Table 111. Macrolide Pharmaceuticals Latest Developments
Table 112. Melinta Therapeutics Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors
Table 113. Melinta Therapeutics Antibiotic Resistance Product Offered
Table 114. Melinta Therapeutics Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 115. Melinta Therapeutics Main Business
Table 116. Melinta Therapeutics Latest Developments
Table 117. Merck Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors
Table 118. Merck Antibiotic Resistance Product Offered
Table 119. Merck Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 120. Merck Main Business
Table 121. Merck Latest Developments
Table 122. Nabriva Therapeutics Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors
Table 123. Nabriva Therapeutics Antibiotic Resistance Product Offered
Table 124. Nabriva Therapeutics Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 125. Nabriva Therapeutics Main Business
Table 126. Nabriva Therapeutics Latest Developments
Table 127. Nemesis Bioscience Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors
Table 128. Nemesis Bioscience Antibiotic Resistance Product Offered
Table 129. Nemesis Bioscience Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 130. Nemesis Bioscience Main Business
Table 131. Nemesis Bioscience Latest Developments
Table 132. Phage Technologies S.A Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors
Table 133. Phage Technologies S.A Antibiotic Resistance Product Offered
Table 134. Phage Technologies S.A Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 135. Phage Technologies S.A Main Business
Table 136. Phage Technologies S.A Latest Developments
Table 137. Tetraphase Pharmaceuticals Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors
Table 138. Tetraphase Pharmaceuticals Antibiotic Resistance Product Offered
Table 139. Tetraphase Pharmaceuticals Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 140. Tetraphase Pharmaceuticals Main Business
Table 141. Tetraphase Pharmaceuticals Latest Developments
Table 142. The Medicines Company Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors
Table 143. The Medicines Company Antibiotic Resistance Product Offered
Table 144. The Medicines Company Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 145. The Medicines Company Main Business
Table 146. The Medicines Company Latest Developments
Table 147. TPfizer Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors
Table 148. TPfizer Antibiotic Resistance Product Offered
Table 149. TPfizer Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 150. TPfizer Main Business
Table 151. TPfizer Latest Developments
Table 152. Westway Health Basic Information, Antibiotic Resistance Manufacturing Base, Sales Area and Its Competitors
Table 153. Westway Health Antibiotic Resistance Product Offered
Table 154. Westway Health Antibiotic Resistance Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 155. Westway Health Main Business
Table 156. Westway Health Latest Developments
List of Figures
Figure 1. Picture of Antibiotic Resistance
Figure 2. Antibiotic Resistance Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antibiotic Resistance Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Antibiotic Resistance Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Antibiotic Resistance Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Type I
Figure 10. Product Picture of Type I
Figure 11. Global Antibiotic Resistance Sales Market Share by Type in 2021
Figure 12. Global Antibiotic Resistance Revenue Market Share by Type (2017-2022)
Figure 13. Antibiotic Resistance Consumed in Oxazolidinones
Figure 14. Global Antibiotic Resistance Market: Oxazolidinones (2017-2022) & (K Pcs)
Figure 15. Antibiotic Resistance Consumed in Lipoglycopeptides
Figure 16. Global Antibiotic Resistance Market: Lipoglycopeptides (2017-2022) & (K Pcs)
Figure 17. Antibiotic Resistance Consumed in Tetracyclines
Figure 18. Global Antibiotic Resistance Market: Tetracyclines (2017-2022) & (K Pcs)
Figure 19. Antibiotic Resistance Consumed in Cephalosporins
Figure 20. Global Antibiotic Resistance Market: Cephalosporins (2017-2022) & (K Pcs)
Figure 21. Antibiotic Resistance Consumed in Combination therapies
Figure 22. Global Antibiotic Resistance Market: Combination therapies (2017-2022) & (K Pcs)
Figure 23. Antibiotic Resistance Consumed in Other
Figure 24. Global Antibiotic Resistance Market: Other (2017-2022) & (K Pcs)
Figure 25. Global Antibiotic Resistance Sales Market Share by Application (2017-2022)
Figure 26. Global Antibiotic Resistance Revenue Market Share by Application in 2021
Figure 27. Antibiotic Resistance Revenue Market by Company in 2021 ($ Million)
Figure 28. Global Antibiotic Resistance Revenue Market Share by Company in 2021
Figure 29. Global Antibiotic Resistance Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global Antibiotic Resistance Revenue Market Share by Geographic Region in 2021
Figure 31. Global Antibiotic Resistance Sales Market Share by Region (2017-2022)
Figure 32. Global Antibiotic Resistance Revenue Market Share by Country/Region in 2021
Figure 33. Americas Antibiotic Resistance Sales 2017-2022 (K Pcs)
Figure 34. Americas Antibiotic Resistance Revenue 2017-2022 ($ Millions)
Figure 35. APAC Antibiotic Resistance Sales 2017-2022 (K Pcs)
Figure 36. APAC Antibiotic Resistance Revenue 2017-2022 ($ Millions)
Figure 37. Europe Antibiotic Resistance Sales 2017-2022 (K Pcs)
Figure 38. Europe Antibiotic Resistance Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa Antibiotic Resistance Sales 2017-2022 (K Pcs)
Figure 40. Middle East & Africa Antibiotic Resistance Revenue 2017-2022 ($ Millions)
Figure 41. Americas Antibiotic Resistance Sales Market Share by Country in 2021
Figure 42. Americas Antibiotic Resistance Revenue Market Share by Country in 2021
Figure 43. United States Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC Antibiotic Resistance Sales Market Share by Region in 2021
Figure 48. APAC Antibiotic Resistance Revenue Market Share by Regions in 2021
Figure 49. China Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)
Figure 53. India Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe Antibiotic Resistance Sales Market Share by Country in 2021
Figure 56. Europe Antibiotic Resistance Revenue Market Share by Country in 2021
Figure 57. Germany Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)
Figure 58. France Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa Antibiotic Resistance Sales Market Share by Country in 2021
Figure 63. Middle East & Africa Antibiotic Resistance Revenue Market Share by Country in 2021
Figure 64. Egypt Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country Antibiotic Resistance Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of Antibiotic Resistance in 2021
Figure 70. Manufacturing Process Analysis of Antibiotic Resistance
Figure 71. Industry Chain Structure of Antibiotic Resistance
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...